Vitamin E analogues as prototypic mitochondria-targeting anti-cancer agents

No Thumbnail Available
File version
Author(s)
Dong, LF
Neuzil, J
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)

J. Neuzil, S. Pervaiz and S. Fulda

Date
2014
Size
File type(s)
Location
License
Abstract

Mitochondria have emerged recently as a novel, intriguing target for anti-caner drugs, owing largely to their importance for proper growth of cancer cells. Destabilization of mitochondria often results in the induction of apoptosis in cancer cells that, consequently, may translate into suppression of tumour growth. A class of mitochondria-targeting compounds, mitocans, comprises several groups of agents with different targets within the mitochondrion. Of these, vitamin E analogues have been recently promoted as agents that disrupt mitochondria by several modes of action. These compounds hold substantial promise as potential anti-cancer drugs of clinical relevance.

Journal Title
Conference Title
Book Title

Mitochondria: The Anti-cancer Target for the Third Millenium

Edition
Volume
Issue
Thesis Type
Degree Program
School
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Cancer cell biology

Molecular targets

Persistent link to this record
Citation
Collections